Author: Nigro, Ersilia; Perrotta, Fabio; Polito, Rita; D'Agnano, Vito; Scialò, Filippo; Bianco, Andrea; Daniele, Aurora
Title: Metabolic Perturbations and Severe COVID-19 Disease: Implication of Molecular Pathways Cord-id: y69u7mr2 Document date: 2020_11_28
ID: y69u7mr2
Snippet: Coronavirus disease (COVID-19) is caused by SARS-CoV-2 virus, which can result in serious respiratory illnesses such as pneumonia leading to respiratory failure. It was first reported in Wuhan, Hubei, China, in December 2019 and rapidly spread globally, becoming a pandemic in March 2020. Among comorbidities observed in SARS-CoV-2 positive patients, hypertension (68.3%) and type 2-diabetes (30.1%) are the most frequent conditions. Although symptoms are highly heterogeneous (ranging from absence o
Document: Coronavirus disease (COVID-19) is caused by SARS-CoV-2 virus, which can result in serious respiratory illnesses such as pneumonia leading to respiratory failure. It was first reported in Wuhan, Hubei, China, in December 2019 and rapidly spread globally, becoming a pandemic in March 2020. Among comorbidities observed in SARS-CoV-2 positive patients, hypertension (68.3%) and type 2-diabetes (30.1%) are the most frequent conditions. Although symptoms are highly heterogeneous (ranging from absence of symptoms to severe acute respiratory failure), patients with metabolic-associated diseases often experience worse COVID-19 outcomes. This review investigates the association between metabolic disorders and COVID-19 severity, exploring the molecular mechanisms potentially underlying this relationship and those that are responsible for more severe COVID-19 outcomes. In addition, the role of the main biological processes that may connect metabolic alterations to SARS-CoV-2 infection such as hyperglycemia, immune system deregulation, ACE-2 receptor modulation, and inflammatory response is described. The impact of metabolic disorders on the prognosis of COVID-19 has major implications in public health especially for countries affected by a high incidence of metabolic diseases.
Search related documents:
Co phrase search for related documents- ace inhibitor and acute respiratory distress syndrome: 1, 2, 3, 4, 5
- ace inhibitor and acute sars respiratory syndrome cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- ace inhibitor and adaptive innate: 1
- ace inhibitor and adipose tissue: 1
- ace inhibitor and lung alveolar: 1
- ace inhibitor and lung injury: 1, 2, 3, 4
- ace inhibitor and lymphocyte count: 1
- ace inhibitor and m1 phenotype: 1
- ace receptor and acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- ace receptor and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39
- ace receptor and acute sars respiratory syndrome cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- ace receptor and acute viral respiratory infection: 1, 2
- ace receptor and adaptive innate: 1, 2, 3
- ace receptor and adaptive innate immune response: 1
- ace receptor and adipose tissue: 1, 2, 3, 4, 5
- ace receptor and liver disease: 1, 2, 3, 4, 5, 6, 7, 8
- ace receptor and liver enzyme: 1
- ace receptor and local inflammation: 1
- ace receptor and losartan olmesartan: 1
Co phrase search for related documents, hyperlinks ordered by date